154 related articles for article (PubMed ID: 28192404)
1. Isoprenylcysteine carboxylmethyltransferase is critical for malignant transformation and tumor maintenance by all RAS isoforms.
Lau HY; Tang J; Casey PJ; Wang M
Oncogene; 2017 Jul; 36(27):3934-3942. PubMed ID: 28192404
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of isoprenylcysteine carboxylmethyltransferase sensitizes common chemotherapies in cervical cancer via Ras-dependent pathway.
Pan Q; Liu R; Banu H; Ma L; Li H
Biomed Pharmacother; 2018 Mar; 99():169-175. PubMed ID: 29331763
[TBL] [Abstract][Full Text] [Related]
3. Isoprenylcysteine carboxylmethyltransferase is associated with nasopharyngeal carcinoma chemoresistance and Ras activation.
Zhu Y; Hu Q; Li H
Biochem Biophys Res Commun; 2019 Aug; 516(3):784-789. PubMed ID: 31253403
[TBL] [Abstract][Full Text] [Related]
4. Isoprenylcysteine carboxylmethyltransferase regulates ovarian cancer cell response to chemotherapy and Ras activation.
Liu Q; Chen J; Fu B; Dai J; Zhao Y; Lai L
Biochem Biophys Res Commun; 2018 Jun; 501(2):556-562. PubMed ID: 29746868
[TBL] [Abstract][Full Text] [Related]
5. Small change, big effect: Taking RAS by the tail through suppression of post-prenylation carboxylmethylation.
Lau HY; Wang M
Small GTPases; 2020 Jul; 11(4):271-279. PubMed ID: 29261009
[TBL] [Abstract][Full Text] [Related]
6. A Potent Isoprenylcysteine Carboxylmethyltransferase (ICMT) Inhibitor Improves Survival in Ras-Driven Acute Myeloid Leukemia.
Marín-Ramos NI; Balabasquer M; Ortega-Nogales FJ; Torrecillas IR; Gil-Ordóñez A; Marcos-Ramiro B; Aguilar-Garrido P; Cushman I; Romero A; Medrano FJ; Gajate C; Mollinedo F; Philips MR; Campillo M; Gallardo M; Martín-Fontecha M; López-Rodríguez ML; Ortega-Gutiérrez S
J Med Chem; 2019 Jul; 62(13):6035-6046. PubMed ID: 31181882
[TBL] [Abstract][Full Text] [Related]
7. Isoprenylcysteine carboxylmethyltransferase is required for the impact of mutant KRAS on TAZ protein level and cancer cell self-renewal.
Chai TF; Manu KA; Casey PJ; Wang M
Oncogene; 2020 Jul; 39(31):5373-5389. PubMed ID: 32561852
[TBL] [Abstract][Full Text] [Related]
8. An improved isoprenylcysteine carboxylmethyltransferase inhibitor induces cancer cell death and attenuates tumor growth in vivo.
Lau HY; Ramanujulu PM; Guo D; Yang T; Wirawan M; Casey PJ; Go ML; Wang M
Cancer Biol Ther; 2014 Sep; 15(9):1280-91. PubMed ID: 24971579
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Isoprenylcysteine Carboxylmethyltransferase Induces Cell-Cycle Arrest and Apoptosis through p21 and p21-Regulated BNIP3 Induction in Pancreatic Cancer.
Manu KA; Chai TF; Teh JT; Zhu WL; Casey PJ; Wang M
Mol Cancer Ther; 2017 May; 16(5):914-923. PubMed ID: 28167504
[TBL] [Abstract][Full Text] [Related]
10. Genetic and pharmacologic analyses of the role of Icmt in Ras membrane association and function.
Svensson AW; Casey PJ; Young SG; Bergo MO
Methods Enzymol; 2006; 407():144-59. PubMed ID: 16757321
[TBL] [Abstract][Full Text] [Related]
11. A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor activity in cancer cells.
Winter-Vann AM; Baron RA; Wong W; dela Cruz J; York JD; Gooden DM; Bergo MO; Young SG; Toone EJ; Casey PJ
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4336-41. PubMed ID: 15784746
[TBL] [Abstract][Full Text] [Related]
12. Isoprenyl carboxyl methyltransferase inhibitors: a brief review including recent patents.
Yang WS; Yeo SG; Yang S; Kim KH; Yoo BC; Cho JY
Amino Acids; 2017 Sep; 49(9):1469-1485. PubMed ID: 28631011
[TBL] [Abstract][Full Text] [Related]
13. The isoprenoid substrate specificity of isoprenylcysteine carboxylmethyltransferase: development of novel inhibitors.
Anderson JL; Henriksen BS; Gibbs RA; Hrycyna CA
J Biol Chem; 2005 Aug; 280(33):29454-61. PubMed ID: 15946942
[TBL] [Abstract][Full Text] [Related]
14. Isoprenylcysteine carboxyl methyltransferase is critical for glioblastoma growth and survival by activating Ras/Raf/Mek/Erk.
Wan W; Xiao W; Pan W; Chen L; Liu Z; Xu J
Cancer Chemother Pharmacol; 2022 Mar; 89(3):401-411. PubMed ID: 35171349
[TBL] [Abstract][Full Text] [Related]
15. Isoprenylcysteine carboxylmethyltransferase regulates mitochondrial respiration and cancer cell metabolism.
Teh JT; Zhu WL; Ilkayeva OR; Li Y; Gooding J; Casey PJ; Summers SA; Newgard CB; Wang M
Oncogene; 2015 Jun; 34(25):3296-304. PubMed ID: 25151967
[TBL] [Abstract][Full Text] [Related]
16. A small molecule inhibitor of isoprenylcysteine carboxymethyltransferase induces autophagic cell death in PC3 prostate cancer cells.
Wang M; Tan W; Zhou J; Leow J; Go M; Lee HS; Casey PJ
J Biol Chem; 2008 Jul; 283(27):18678-84. PubMed ID: 18434300
[TBL] [Abstract][Full Text] [Related]
17. NRAS is unique among RAS proteins in requiring ICMT for trafficking to the plasma membrane.
Ahearn IM; Court HR; Siddiqui F; Abankwa D; Philips MR
Life Sci Alliance; 2021 May; 4(5):. PubMed ID: 33579760
[TBL] [Abstract][Full Text] [Related]
18. A requirement for wild-type Ras isoforms in mutant KRas-driven signalling and transformation.
Bentley C; Jurinka SS; Kljavin NM; Vartanian S; Ramani SR; Gonzalez LC; Yu K; Modrusan Z; Du P; Bourgon R; Neve RM; Stokoe D
Biochem J; 2013 Jun; 452(2):313-20. PubMed ID: 23496764
[TBL] [Abstract][Full Text] [Related]
19. Discovery and SAR of methylated tetrahydropyranyl derivatives as inhibitors of isoprenylcysteine carboxyl methyltransferase (ICMT).
Judd WR; Slattum PM; Hoang KC; Bhoite L; Valppu L; Alberts G; Brown B; Roth B; Ostanin K; Huang L; Wettstein D; Richards B; Willardsen JA
J Med Chem; 2011 Jul; 54(14):5031-47. PubMed ID: 21661760
[TBL] [Abstract][Full Text] [Related]
20. 9 Structure and function of isoprenylcysteine carboxylmethyltransferase (Icmt): A key enzyme in CaaX processing.
Anderson JL; Hrycyna CA
Enzymes; 2006; 24():245-72. PubMed ID: 26718043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]